MEDLOT PAIN RELIEF GEL PATCH- lidocaine patch, extended release

medlot pain relief gel patch by

Drug Labeling and Warnings

medlot pain relief gel patch by is a Otc medication manufactured, distributed, or labeled by Lotfancy, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient

Lidocaine 4%

Uses

Temporarily relieves minor aches and pains

Warnings

For external use only

Do not use:

• More than 1 patch on your body at a time
• On wounds, damaged, irritated or swollen skin
• For more than one week without consulting a doctor
• If you are allergic to any active or inactive ingredients

When using this product:

• Use only as directed
• Avoid contact with eyes and mucous membranes
• Do not bandage tightly or apply local heat (such as heating pads) to the area
• Do not use with other topical analgesics at the same time
• Dispose of used patches safely, always keeping them away from children and pets
• Used patches still contain medication that can cause serious harm if chewed or ingested
• A temporary burning sensation may occur upon application but usually goes away in a few days
• If a severe burning sensation occurs, stop use immediately

Stop use and ask a doctor if:

• Condition worsens
• You experience signs of skin injury, such as redness, irritation, pain, swelling, or blistering where the product was applied
• Symptoms persist for more than 7 days, or clear up and return within a few days

If pregnant or breastfeeding

Ask a healthcare professional before use

Keep out of reach of children and pets.

If swallowed, get medical help or contact a Poison Control Center immediately

Directions

Adults and children over 12 years:

• Clean and dry the affected area
• Remove the protective film by firmly grasping both ends and gently puling until it separate in the middle
• Carefully peel back part of the protective film and apply the exposed part of the patch to the affected area
• Remove the remaining film while pressing the patch firmly to the skin
• Use 1 patch for up to 8 hours

Children 12 years and under: Ask a doctor

Other Information

Store at room temperature (20-25 C / 68-77 F)

Inactive Ingredients

Glycerin, Sodium polyacrylate, Water, Methylparaben, Propylparaben, Dihydroxyaluminum aminoacetate, Tartaric acid, PVP, Polysorbate 80, Kaolin, Titanium Dioxide, Propylene glycol, Polyacrylic acid

Questions or Comments

864-432-4006 support@medlotsupply.com

Administration

Remove patch from outer package.

Partially peel back protective film.

Place on affected area.

Remove remaining film while pressing patch to skin.

Uses

Temporarily Relieves minor aches and pains.

• Back
• Neck & Shoulders
• Knees & Elbows

4% lidocaine pain relief gel patch

INGREDIENTS AND APPEARANCE

MEDLOT PAIN RELIEF GEL PATCH 
lidocaine patch, extended release

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 87054-105
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	40 mg  in 40 mg

Inactive Ingredients
Ingredient Name	Strength
PVP (UNII: FZ989GH94E)
GLYCERIN (UNII: PDC6A3C0OX)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
WATER (UNII: 059QF0KO0R)
TARTARIC ACID (UNII: W4888I119H)
POLYSORBATE 80 (UNII: 6OZP39ZG8H)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)
DIHYDROXYALUMINUM AMINOACETATE (UNII: DO250MG0W6)
POLYACRYLIC ACID (8000 MW) (UNII: 73861X4K5F)
METHYLPARABEN (UNII: A2I8C7HI9T)
KAOLIN (UNII: 24H4NWX5CO)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 87054-105-05	5 in 1 BOX	01/01/2026
1	NDC: 87054-105-01	40 mg in 1 POUCH; Type 0: Not a Combination Product
2	NDC: 87054-105-32	32 in 1 BOX	01/01/2026
2	NDC: 87054-105-01	40 mg in 1 POUCH; Type 0: Not a Combination Product
3	NDC: 87054-105-16	16 in 1 BOX	01/01/2026
3	NDC: 87054-105-01	40 mg in 1 POUCH; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	01/01/2026

Labeler - Lotfancy, Inc. (009651371)